AGP Executive Report
Last update: 2 hours agoAir Pollution: Delhi-NCR endured severe Diwali pollution despite restrictions, raising fresh health concerns; Mumbai fared better, with its cleanest Diwali afternoon air in four years, though AQI remained moderate. TB Care: Tamil Nadu’s programme to identify severely ill patients and fast-track hospital care was linked to at least a 38% drop in TB deaths across diagnosis cohorts. Cancer Treatment: Revised prices for anti-cancer medicines take effect November 9, with estimated annual savings for patients of more than ₹3,500 crore. Medicine Safety: ED raids in Bengaluru uncovered low-cost drugs allegedly repackaged and relabelled as Pfizer antibiotics, while pharma companies seek CDSCO clarity on new solvent clearances, warning of possible supply disruptions. Hospital Care: KEM Hospital doctors discharged a baby born at 700 grams after five months in intensive care; he weighed 3.3 kg and was fully breastfed. Medical Research: Zydus reported positive Phase 2b results for saroglitazar in patients with MASH and liver fibrosis.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.